SCHEMBL3296406

SCHEMBL3296406

CC(C)C1CCCc2ccccc21

nearest known ligand 0.53

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.49
PRCP P42785 1/20 0.49
CHRNA7 P36544 1/20 0.43
PDPK1 O15530 1/20 0.43
GID4 Q8IVV7 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrogen Peroxide SCHEMBL9456544 0.96 IDO1 (0.46) IDO1PRCP
SCHEMBL3000155 0.89 IDO1 (0.49) IDO1PRCPCHRNA7PDPK1GID4
SCHEMBL835606 0.88 PRCP (0.52) IDO1PRCPPDPK1
SCHEMBL30298334 0.88 PRCP (0.52) IDO1PRCPPDPK1
SCHEMBL30298337 0.88 PRCP (0.52) IDO1PRCPPDPK1
SCHEMBL19289528 0.85 SIGMAR1 (0.42) PRCPCHRNA7
SCHEMBL15540606 0.85 IDO1 (0.50) IDO1PRCPCHRNA7PDPK1GID4
SCHEMBL4081534 0.85 IDO1 (0.46) IDO1PRCPCHRNA7PDPK1GID4
SCHEMBL13006752 0.85 IDO1 (0.50) IDO1PRCPCHRNA7PDPK1GID4
Methyl Alcohol SCHEMBL14815578 0.85 PRCP (0.49) IDO1PRCPPDPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4460557-A Starting pitches for carbon fibers NIPPON OIL CO., LTD. (JP) 1984-07-17 US claimed
US-20240400784-A1 Method for Screening Solvent for Extracting Polyvinyl Chloride, Method for Recycling Waste, Recycled Polyvinyl Chloride, and Composition LG CHEM, LTD. (KR) 2024-12-05 US disclosed
US-20230159573-A1 SMALL MOLECULE STAT PROTEIN DEGRADERS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2023-05-25 US disclosed
US-20230139282-A1 ANTIMALARIAL AGENTS MERCK SHARP & DOHME LLC (US) 2023-05-04 US disclosed
WO-2023069514-A2 BIFUNCTIONAL COMPOUNDS FOR DEGRADING ITK VIA UBIQUITIN PROTEOSOME PATHWAY NURIX THERAPEUTICS, INC. (US) 2023-04-27 WO disclosed
US-11312724-B2 Spirocyclic tetrahydroquinazolines ASCENTAGE PHARMA (SUZHOU) CO., LTD. 2022-04-26 US disclosed
US-20210230174-A1 SPIROCYCLIC TETRAHYDROQUINAZOLINES ASCENTAGE PHARMA (SUZHOU) CO., LTD. (CN) 2021-07-29 US disclosed
WO-2021139748-A1 SPIROCYCLIC TETRAHYDROQUINAZOLINES ASCENTAGE PHARMA (SUZHOU) CO., LTD. (CN) 2021-07-15 WO disclosed
US-20210009557-A1 ACYCLIC CXCR4 INHIBITORS AND USES THEREOF X4 PHARMACEUTICALS, INC. 2021-01-14 US disclosed
EP-3489219-B1 THERAPEUTIC AGENT FOR GLAUCOMA TOA EIYO LTD (JP) 2020-12-16 EP disclosed
EP-0063052-B1 STARTING PITCHES FOR CARBON FIBERS NIPPON OIL CO. LTD. (JP) 1986-09-03 EP disclosed
EP-0063053-B1 STARTING PITCHES FOR CARBON FIBERS NIPPON OIL CO. LTD. (JP) 1986-03-12 EP disclosed
US-4521294-A Starting pitches for carbon fibers NIPPON OIL CO., LTD. (JP) 1985-06-04 US disclosed
US-4470960-A Process for the production of pitch-derived carbon fibers NIPPON OIL CO., LTD. (JP) 1984-09-11 US disclosed
US-4469667-A MIXING WITH HYDROGENATED AROMATIC HYDROCARBON NIPPON OIL CO., LTD. (JP) 1984-09-04 US disclosed
US-4460557-A Starting pitches for carbon fibers NIPPON OIL CO., LTD. (JP) 1984-07-17 US disclosed
US-4397830-A HEAT TREATMENT OF HEAVY OIL AND HYDROGENATED HEAVY OIL NIPPON OIL CO., LTD. (JP) 1983-08-09 US disclosed
EP-0063053-A2 Starting pitches for carbon fibers NIPPON OIL CO. LTD. (JP) 1982-10-20 EP disclosed
EP-0063052-A2 Starting pitches for carbon fibers NIPPON OIL CO. LTD. (JP) 1982-10-20 EP disclosed
US-4288837-A Electrical capacitor NISHIMATSU MINEAKI 1981-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230139282-A1 ANTIMALARIAL AGENTS G6PD, MTX1, OAT IDO1 1843/4885PRCP 206/4885CHRNA7 4619/4885
US-20210230174-A1 SPIROCYCLIC TETRAHYDROQUINAZOLINES KRAS, NRAS, HRAS IDO1 4674/4885PRCP 3796/4885CHRNA7 4822/4885
US-20210009557-A1 ACYCLIC CXCR4 INHIBITORS AND USES THEREOF CXCR4, CXCR3, CXCR1 IDO1 2660/4885PRCP 1163/4885CHRNA7 1630/4885
US-11312724-B2 Spirocyclic tetrahydroquinazolines KRAS, NRAS, HRAS IDO1 4674/4885PRCP 3796/4885CHRNA7 4822/4885
US-20230159573-A1 SMALL MOLECULE STAT PROTEIN DEGRADERS STAT1, STAT3, STAT5A IDO1 2186/4885PRCP 1086/4885CHRNA7 4817/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.